Delivery Order SPE2DB24D2003-SPE2DB24FXEE7

Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $3.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.98 firm fixed-price delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,027.44 firm fixed-price delivery order is for the supply of FYCOMPA 8 MG Tablet 30s, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,036.72 firm-fixed-price delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award, valued at $1,027.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of March 10, 2025. The contract covers the procurement of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product, for the DLA. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,002.33, is a delivery order for the supply of FYCOMPA 2 MG TABLET 30S. The award has an ultimate completion date of March 17, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,011.33 firm fixed-price delivery order contract is for the supply of FYCOMPA 2 MG TABLET 30S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of November 7, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,913.11 firm fixed-price delivery order is for the supply of FYCOMPA 6 MG TABLET 30S, a medication used for the treatment of partial-onset seizures. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,027.44 firm fixed-price delivery order is for the supply of the prescription drug FYCOMPA 8 MG TABLET 30S. The contract has an ultimate completion date of December 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.98 firm-fixed-price delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product, with a completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,067.96, is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of February 27, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXEE7
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.34 firm fixed-price delivery order is for the supply of FYCOMPA 6 MG TABLET 30S, a pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract has no set-aside designation, indicating open competition.

AmerisourceBergen is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. This award demonstrates the company's capacity to meet the diverse pharmaceutical needs of the U.S. government, particularly the military and veterans' healthcare programs, through its extensive supply chain and distribution capabilities.

Generated 5/16/25, 12:38 PM